Annual EBIT
-$11.46 M
+$8.80 M+43.44%
December 31, 2023
Summary
- As of February 7, 2025, PCSA annual earnings before interest & taxes is -$11.46 million, with the most recent change of +$8.80 million (+43.44%) on December 31, 2023.
- During the last 3 years, PCSA annual EBIT has risen by +$3.68 million (+24.29%).
- PCSA annual EBIT is now -12380.50% below its all-time high of -$91.80 thousand, reached on December 31, 2016.
Performance
PCSA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.42 M
-$342.90 K-11.13%
September 30, 2024
Summary
- As of February 7, 2025, PCSA quarterly earnings before interest & taxes is -$3.42 million, with the most recent change of -$342.90 thousand (-11.13%) on September 30, 2024.
- Over the past year, PCSA quarterly EBIT has dropped by -$615.30 thousand (-21.90%).
- PCSA quarterly EBIT is now -16725.73% below its all-time high of $20.60 thousand, reached on June 30, 2017.
Performance
PCSA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$11.79 M
-$1.26 M-11.94%
September 30, 2024
Summary
- As of February 7, 2025, PCSA TTM earnings before interest & taxes is -$11.79 million, with the most recent change of -$1.26 million (-11.94%) on September 30, 2024.
- Over the past year, PCSA TTM EBIT has dropped by -$1.62 million (-15.99%).
- PCSA TTM EBIT is now -45939.06% below its all-time high of -$25.60 thousand, reached on June 30, 2017.
Performance
PCSA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PCSA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.4% | -21.9% | -16.0% |
| 3 y3 years | +24.3% | +41.0% | +41.8% |
| 5 y5 years | -154.2% | +41.0% | +41.8% |
PCSA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.4% | -58.0% | +43.5% | -16.0% | +44.2% |
| 5 y | 5-year | -192.0% | +43.4% | -327.0% | +67.0% | -218.3% | +44.2% |
| alltime | all time | <-9999.0% | +43.4% | <-9999.0% | +67.0% | <-9999.0% | +44.2% |
Processa Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.42 M(+11.1%) | -$11.79 M(+11.9%) |
| Jun 2024 | - | -$3.08 M(+9.7%) | -$10.53 M(+3.6%) |
| Mar 2024 | - | -$2.81 M(+13.8%) | -$10.16 M(-11.3%) |
| Dec 2023 | -$11.46 M(-43.4%) | -$2.47 M(+13.9%) | -$11.46 M(-22.5%) |
| Sep 2023 | - | -$2.17 M(-20.1%) | -$14.79 M(-20.8%) |
| Jun 2023 | - | -$2.71 M(-33.9%) | -$18.68 M(-11.6%) |
| Mar 2023 | - | -$4.11 M(-29.2%) | -$21.13 M(+4.3%) |
| Dec 2022 | -$20.26 M(+75.1%) | -$5.80 M(-4.2%) | -$20.26 M(+13.6%) |
| Sep 2022 | - | -$6.06 M(+17.1%) | -$17.83 M(+20.2%) |
| Jun 2022 | - | -$5.17 M(+60.2%) | -$14.83 M(+14.5%) |
| Mar 2022 | - | -$3.23 M(-4.2%) | -$12.95 M(+8.7%) |
| Dec 2021 | -$11.57 M(-23.6%) | -$3.37 M(+10.1%) | -$11.91 M(-37.1%) |
| Sep 2021 | - | -$3.06 M(-7.1%) | -$18.93 M(+0.6%) |
| Jun 2021 | - | -$3.29 M(+50.5%) | -$18.83 M(+15.3%) |
| Mar 2021 | - | -$2.19 M(-78.9%) | -$16.34 M(+7.9%) |
| Dec 2020 | -$15.13 M(+285.7%) | -$10.39 M(+251.6%) | -$15.13 M(+167.6%) |
| Sep 2020 | - | -$2.96 M(+268.5%) | -$5.66 M(+52.8%) |
| Jun 2020 | - | -$802.00 K(-18.7%) | -$3.70 M(-8.2%) |
| Mar 2020 | - | -$986.40 K(+8.2%) | -$4.03 M(+2.8%) |
| Dec 2019 | -$3.92 M(-12.9%) | -$911.30 K(-9.1%) | -$3.92 M(+4.7%) |
| Sep 2019 | - | -$1.00 M(-11.6%) | -$3.75 M(-1.4%) |
| Jun 2019 | - | -$1.13 M(+29.3%) | -$3.80 M(-7.1%) |
| Mar 2019 | - | -$876.50 K(+19.4%) | -$4.09 M(-9.2%) |
| Dec 2018 | -$4.51 M | -$733.80 K(-30.5%) | -$4.51 M(-16.8%) |
| Sep 2018 | - | -$1.06 M(-25.9%) | -$5.42 M(+19.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$1.43 M(+10.5%) | -$4.52 M(+47.0%) |
| Mar 2018 | - | -$1.29 M(-21.6%) | -$3.07 M(+71.0%) |
| Dec 2017 | -$1.80 M(+1857.8%) | -$1.65 M(+939.7%) | -$1.80 M(+904.6%) |
| Sep 2017 | - | -$158.30 K(-868.4%) | -$178.90 K(+598.8%) |
| Jun 2017 | - | $20.60 K(-250.4%) | -$25.60 K(-14.7%) |
| Mar 2017 | - | -$13.70 K(-50.2%) | -$30.00 K(-67.3%) |
| Dec 2016 | -$91.80 K(-96.7%) | -$27.50 K(+450.0%) | -$91.80 K(-68.9%) |
| Sep 2016 | - | -$5000.00(-130.9%) | -$295.10 K(-35.5%) |
| Jun 2016 | - | $16.20 K(-121.5%) | -$457.40 K(-80.7%) |
| Mar 2016 | - | -$75.50 K(-67.3%) | -$2.37 M(-13.9%) |
| Dec 2015 | -$2.75 M(-18.5%) | -$230.80 K(+38.0%) | -$2.75 M(-14.2%) |
| Sep 2015 | - | -$167.30 K(-91.2%) | -$3.20 M(-13.4%) |
| Jun 2015 | - | -$1.89 M(+313.9%) | -$3.70 M(+45.4%) |
| Mar 2015 | - | -$457.10 K(-33.4%) | -$2.54 M(-24.5%) |
| Dec 2014 | -$3.37 M(+13.9%) | -$686.00 K(+3.7%) | -$3.37 M(-3.1%) |
| Sep 2014 | - | -$661.80 K(-10.4%) | -$3.48 M(-0.3%) |
| Jun 2014 | - | -$738.30 K(-42.5%) | -$3.49 M(+1.3%) |
| Mar 2014 | - | -$1.28 M(+62.1%) | -$3.44 M(+16.3%) |
| Dec 2013 | -$2.96 M(+30.4%) | -$792.20 K(+17.6%) | -$2.96 M(+0.9%) |
| Sep 2013 | - | -$673.40 K(-2.8%) | -$2.93 M(+3.8%) |
| Jun 2013 | - | -$692.80 K(-13.5%) | -$2.83 M(+11.3%) |
| Mar 2013 | - | -$800.50 K(+4.5%) | -$2.54 M(+11.9%) |
| Dec 2012 | -$2.27 M | -$766.30 K(+35.1%) | -$2.27 M(+51.0%) |
| Sep 2012 | - | -$567.10 K(+40.0%) | -$1.50 M(+60.6%) |
| Jun 2012 | - | -$405.20 K(-23.7%) | -$936.40 K(+76.3%) |
| Mar 2012 | - | -$531.20 K | -$531.20 K |
FAQ
- What is Processa Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual EBIT year-on-year change?
- What is Processa Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly EBIT year-on-year change?
- What is Processa Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals TTM EBIT year-on-year change?
What is Processa Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of PCSA is -$11.46 M
What is the all time high annual EBIT for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual earnings before interest & taxes is -$91.80 K
What is Processa Pharmaceuticals annual EBIT year-on-year change?
Over the past year, PCSA annual earnings before interest & taxes has changed by +$8.80 M (+43.44%)
What is Processa Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of PCSA is -$3.42 M
What is the all time high quarterly EBIT for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly earnings before interest & taxes is $20.60 K
What is Processa Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, PCSA quarterly earnings before interest & taxes has changed by -$615.30 K (-21.90%)
What is Processa Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of PCSA is -$11.79 M
What is the all time high TTM EBIT for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high TTM earnings before interest & taxes is -$25.60 K
What is Processa Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, PCSA TTM earnings before interest & taxes has changed by -$1.62 M (-15.99%)